Latest Erythropoietin Stories
CARLSBAD, Calif. and VANCOUVER, Canada, Nov. 16, 2010 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Xenon Pharmaceuticals Inc.
Scientists are reporting development of a long-sought method with the potential for getting medication through a biological barrier that surrounds the brain, where it may limit the brain damage caused by stroke.
BURLINGTON, Mass., Nov.
DALLAS, November 1, 2010 /PRNewswire/ -- Sandler Research announces it will carry Anemia - Pipeline Assessment and Market Forecasts to 2017 Research Report in its store. Browse the complete Report on: http://www.sandlerresearch.org/reports/37162-anemia-pipeline-assessment-and-m arket-forecasts-to-2017.html Browse All Food and Beverages Reports: http://www.sandlerresearch.org/market-research/pharmaceuticals/ Search More Then 20000 Market Research Reports at...
EXTON, Pa., Oct. 27 /PRNewswire/ -- BioTrends Research Group, Inc. released two syndicated Nephrology TreatmentTrendsÂ® publications (TreatmentTrendsÂ®: US Nephrology Q310 and TreatmentTrendsÂ®: Renal Dietitians 2010).
As if high blood pressure, chronic diseases, and cancer weren't enough, high levels of erythropoietin in people over 85 join the list of silent killers.
High erythropoietin levels in people over age 85 indicate a higher risk of death.
THOUSAND OAKS, Calif., Oct.
EXTON, Pa., Oct. 6 /PRNewswire/ -- BioTrends Research Group, Inc. recently published its TreatmentTrendsÂ®: Renal Anemia in China report.
THOUSAND OAKS, Calif., Oct. 5 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced that results from several important studies from the Company's oncology portfolio will be presented at the 35th European Society for Medical Oncology (ESMO) Congress, Oct. 8-12, 2010, in Milan, Italy.
- An armed gangster.